Lav Leads $19M Series B Funding In Novlead Biotech
11/18/21, 4:52 PM
Money raised
$19 million
Round Type
series b
Medical devices maker Novlead Biotech announced on Tuesday that it has garnered 120 million yuan ($19 million) in a Series B round of financing led by the biomedical-focussed venture capital firm Lilly Asia Ventures (LAV).